Abstract:Background Anti-tumor necrosis factor alpha (TNF- α ) therapy has made a significant impact on treating psoriasis. Despite these agents being designed to block TNF- α activity, their mechanism of action in the remission of psoriasis is still not fully understood at the molecular level. Results To better understand the molecular mechanisms of Anti-TNF- α therapy, we analysed the global gene expression profile (using mRNA microarray) in peripheral blood mononuclear cells (PBMCs) that were collected from 6 psoriasis patients before and 12 weeks after the treatment of etanercept. First, we identified 176 differentially expressed genes (DEGs) before and after treatment by using paired t-test. Then, we constructed the gene co-expression modules by weighted correlation network analysis (WGCNA), and 22 co-expression modules were found to be significantly correlated with treatment response. Of these 176 DEGs, 79 DEGs (M_DEGs) were the members of these 22 co-expression modules. Of the 287 GO functional processes and pathways that were enriched for these 79 M_DEGs, we identified 30 pathways whose overall gene expression activities were significantly correlated with treatment response. Of the original 176 DEGs, 19 (GO_DEGs) were found to be the members of these 30 pathways, whose expression profiles showed clear discrimination before and after treatment. As expected, of the biological processes and functionalities implicated by these 30 treatment response-related pathways, the inflammation and immune response was the top pathway in response to etanercept treatment, and some known TNF- α related pathways, such as molting cycle process, hair cycle process, skin epidermis development, regulation of hair follicle development, were implicated. Furthermore, additional novel pathways were also suggested, such as heparan sulfate proteoglycan metabolic process, vascular endothelial growth factor production, whose transcriptional regulation may mediate the response to etanercept treatment. Conclusion Through global gene expression analysis in PBMC of psoriasis patient and subsequent co-expression module based pathway analyses, we have identified a group of functionally coherent and differentially expressed genes (DEGs) and related pathways, which has not only provided new biological insight about the molecular mechanism of anti-TNF- α treatment, but also identified several genes whose expression profiles can be used as potential biomarkers for anti-TNF- α treatment response in psoriasis.

Effect of pharmacological intervention on MIP-1α, MIP-1β and MCP-1 expression in patients with psoriasis vulgaris

Anti-TNF- Αtreatment-Related Pathways and Biomarkers Revealed by Transcriptome Analysis in Chinese Psoriasis Patients

Increased Endocytic Activity in Monocyte-Derived Dendritic Cells in Patients with Psoriasis Vulgaris

The Effect Of Calcitonin Gene-Related Peptide On T Lymphocyte Infiltration And Its Role In The Therapeutic Effects Of Acitretin In Psoriasis Vulgaris

Expression of Vascular Endothelial Growth Factor and Monocyte Chemoattractant Protein- 1 in Patients with Psoriasis

Increased serum level of chemokine CCL27 in patients with psoriasis vulgaris,and its clinical relevance

Evaluation of the inflammatory parameters as potential biomarkers of systemic inflammation extent and the disease severity in psoriasis patients

The Effect of Secukinumab Treatment for Psoriasis on Serum Cytokines and Correlation with Disease Severity

The Expression of Chemokine Receptors on Neutrophils in Patients with Psoriasis Vulgaris

Serum Expression of Monocyte Chemoattractant Protein-1 and Macrophage Inhibitory Protein-1Α in Patients with Rheumatoid Arthritis

Effect of Acitretin on the Th1/Th2 balance in lesions of psoriatic vulgaris patients

Study on Inflammatory Factors Secreted by Neutrophils in Patients with Psoriasis Vulgaris

Expression Of Tumor Necrosis Factor Alpha-Induced Protein 3 Mrna In Peripheral Blood Mononuclear Cells Negatively Correlates With Disease Severity In Psoriasis Vulgaris

Expression of CD147,cyclophilin A and cyclophilin B in patients with psoriasis

Effect of Chinese herbal medicine injections for treatment of psoriasis vulgaris: a systematic review and meta-analysis

Expression of CXCR3 Mrna in Lesions and Peripheral Blood Mononuclear Cell(pbmc)of Patients with Psoriasis Vulgaris

Dendritic Cells,Natural Killer Cells and Adhesion Molecules in Psoriasis

New findings of macrophages in initiating and sustaining psoriasis

Expression of Pro-Angiogenic Genes in Mesenchymal Stem Cells Derived from Dermis of Patients with Psoriasis

Circulating microRNA profile unveils mechanisms of action of acitretin for psoriasis vulgaris

MicroRNA‐146a and microRNA‐146b deficiency correlates with exacerbated disease activity, and their longitude increment relates to etanercept response in psoriasis patients